Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant

Bone Marrow Transplantation
K A Sepkowitz

Abstract

Effective prophylaxis against specific infections has allowed increasingly potent conditioning regimens to be given, thereby prolonging survival in HSCT recipients. The Centers for Disease Control and Prevention, in collaboration with numerous professional societies, has recently published guidelines to codify and advance this approach. Controversy remains in several areas but, curiously, the most intense debate concerns prevention of bacterial infections, the most extensively studied of all of the approaches. Central to this debate are the competing priorities of a potentially ill patient on the one hand vs the long-term consequences of unchecked antibiotic use. The emergence in the 1990s of vancomycin-resistant Enterococcus demonstrated all too vividly how devastating such an end result could be. This article will review the arguments for and against the routine use of antibacterial prophylaxis in HSCT recipients.

References

Jun 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingB H Keefe
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M AttalG Laurent
Jan 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Y BochudP Francioli
Sep 1, 1994·The American Journal of Medicine·P Y BochudP Francioli
Apr 28, 1994·The New England Journal of Medicine·A ComettaM P Glauser
Oct 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M CrucianiE Concia
Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M MurphyD Armstrong
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E A EngelsM Barza
Aug 31, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·N AlfieriD R Cook
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A MarronF Gudiol
Apr 25, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D J DiekemaUNKNOWN SENTRY Participants Group
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones
Sep 18, 2001·Current Infectious Disease Reports·Eugénie Bergogne-Bérézin

❮ Previous
Next ❯

Citations

Dec 6, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B S SohnC Suh
Jul 15, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Krzysztof KalwakAlicja Chybicka
Oct 12, 2011·Current Opinion in Infectious Diseases·Alistair B ReidLeon J Worth
Dec 19, 2012·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Vivek G BhatNavin Khattry
Oct 7, 2008·Scandinavian Journal of Infectious Diseases·Sari HamalainenE Jantunen
Apr 28, 2009·European Journal of Internal Medicine·Abdul Rahman Safadi, Ayman O Soubani
Dec 14, 2004·Pediatric Blood & Cancer·Leslie S KersunAngela Demichele
Aug 17, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·C-H LaiY-J Yang
Oct 9, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Khalil UllahFarrukh Mahmood Akhtar
Nov 13, 2014·PloS One·Michiel B HaesekerAnnelies Verbon
Oct 24, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Amber B ClemmonsJeremy Pantin
Jan 26, 2021·Medical Journal, Armed Forces India·J S GillAshwini Agarwal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
C P Gibbons
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Khalil UllahFarrukh Mahmood Akhtar
© 2022 Meta ULC. All rights reserved